Literature DB >> 6323283

Androgen, estrogen and progestin cytosol receptor concentrations in the normal human endometrium. Effects of intrauterine device.

R Punnonen, K Pettersson, R Vanharanta.   

Abstract

The specific androgen, estrogen and progestin binding was studied in normal human endometrium during various phases of the menstrual cycle. The simultaneous presence of these three hormone receptors was a common finding. Androgen receptor concentrations did not show cyclic variations. A copper intrauterine device had no effect on the endometrial androgen, estrogen and progestin receptor concentrations.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6323283     DOI： 10.1159/000299125

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN： 0378-7346            Impact factor:   2.031


  3 in total

1.  DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.

Authors:  R Punnonen; J Mattila; T Kuoppala; T Koivula
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Immunohistochemical study of distribution of estrogen receptors in corpus and cervix uteri.

Authors:  A Scharl; M Vierbuchen; J Graupner; R Fischer; A Bolte
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

3.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Authors:  Ashley S Felix; Mia M Gaudet; Carlo La Vecchia; Christina M Nagle; Xiao Ou Shu; Elisabete Weiderpass; Hans Olov Adami; Shirley Beresford; Leslie Bernstein; Chu Chen; Linda S Cook; Immaculata De Vivo; Jennifer A Doherty; Christine M Friedenreich; Susan M Gapstur; Dierdre Hill; Pamela L Horn-Ross; James V Lacey; Fabio Levi; Xiaolin Liang; Lingeng Lu; Anthony Magliocco; Susan E McCann; Eva Negri; Sara H Olson; Julie R Palmer; Alpa V Patel; Stacey Petruzella; Jennifer Prescott; Harvey A Risch; Lynn Rosenberg; Mark E Sherman; Amanda B Spurdle; Penelope M Webb; Lauren A Wise; Yong-Bing Xiang; Wanghong Xu; Hannah P Yang; Herbert Yu; Anne Zeleniuch-Jacquotte; Louise A Brinton
Journal:  Int J Cancer       Date:  2014-09-30       Impact factor: 7.316
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.